Opus Genetics, Inc. (IRD)
3.64
+0.25
(+7.37%)
USD |
NASDAQ |
Feb 13, 16:00
3.635
0.00 (0.00%)
After-Hours: 20:00
Opus Genetics Market Cap : 251.03M for Feb. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 16.50B |
| ACADIA Pharmaceuticals, Inc. | 3.727B |
| Alnylam Pharmaceuticals, Inc. | 41.70B |
| Savara, Inc. | 1.139B |
| BioMarin Pharmaceutical, Inc. | 11.50B |
Market Cap Related Metrics
| PS Ratio | 12.40 |
| PEG Ratio | -0.0364 |
| Price to Book Value | 42.07 |
| Price | 3.64 |
| Earnings Yield | -47.22% |
| PEGY Ratio | -0.0364 |